The RSV vaccine is different. It does not have a reputation problem or a trust problem. It has an awareness problem.
But timing matters: When administered at least 8 weeks before delivery, maternal vaccination appears equally effective.
One of the 6 studies shows that, given alone or together, maternal RSV vaccination and infant immunization with nirsevimab are safe and trigger a good immune response.
Most reactions to the RSV immunization were mild and temporary, and serious adverse events were rare.
People who got the vaccines at the same time had roughly the same immune response as those who got them separately, with few serious side effects.
Infants younger than 6 months made up 42% of RSV hospital admissions and 62% of ICU admissions.
Pediatric flu deaths so far this season now total 149, most of them in unvaccinated children.
Increased post-COVID risk was noted for pulmonary embolism, abnormal breathing, fatigue, hemorrhagic stroke, brain fog, and palpitations.
The 30- and 90-day mortality rates for infected patients were 12% and 19%, respectively.
So far this season, 139 children have died from the virus, and about 85% with a known vaccination status were unvaccinated.
